Ahmad shares his skepticism about the medical industrial complex and its profit-driven motives, particularly regarding mRNA technology. William discusses the historical challenges of lipid nanoparticles in cancer treatment, highlighting their inability to deliver chemotherapy effectively and the failures of mRNA applications in the past. Both express apprehension about the rapid rollout of mRNA technology without proven success.
